BTL Unveils New Laser Division with EXOLASE ONE® Launch

BTL, a leader in energy-based medical and aesthetic technologies, has announced the creation of a new laser division and the launch of EXOLASE ONE®, the first fused erbium laser. This breakthrough integrates multiple wavelengths into a single beam, setting a new standard in laser facial rejuvenation. The technology simplifies procedures, allowing a full facial treatment in under 10 minutes with improved results.

This innovation is part of BTL's extensive R&D efforts and marks a significant step in its corporate history. EXOLASE ONE® aims for a global launch in 2027, initially targeting aesthetic medicine and dermatology. The new division complements BTL's areas, including aesthetics and rehabilitation.